Ionis Pharmaceuticals (IONS), Alnylam (ALNY), and BioMarin Pharmaceutical (BMRN) were among the gainers on Tuesday after Citi launched the SMid Cap Biotech group with a bullish view, citing compelling growth and catalyst outlook.

In a research note on Monday, Citi analyst